Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology

Laboratory Investigation

Volumn 96, Issue 4, 2016, Pages 378-390

  Suárez Álvarez, Beatriz ^a,b   Liapis, Helen ^c,d   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Nephropath ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; BLEEDING; BLOOD CLOTTING; CHRONIC KIDNEY DISEASE; EPITHELIZATION; GENETIC VARIABILITY; HISTOLOGY; HUMAN; INFECTION CONTROL; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; MESENCHYME; NEPHRON; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SURVIVAL; TISSUE REGENERATION; BIOLOGICAL MODEL; CHRONIC KIDNEY FAILURE; EPITHELIUM; FIBROSIS; KIDNEY; PATHOLOGY; PHYSIOLOGY; REGENERATION;

ACUTE KIDNEY INJURY; BLOOD COAGULATION; EPITHELIUM; FIBROSIS; HUMANS; INFLAMMATION; KIDNEY; MODELS, BIOLOGICAL; REGENERATION; RENAL INSUFFICIENCY, CHRONIC;

EID: 84962294154     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.164     Document Type: Review

References (167)

1. Gurtner GC, Werner S, Barrandon Y et al. Wound repair and regeneration. Nature 2008;453:314-321.
2. Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009;37: 1528-1542.
3. Smith SA, Travers RJ, Morrissey JH. How it all starts: initiation of the clotting cascade. Crit Rev Biochem Mol Biol 2015;28:1-11.
4. Jennewein C, Paulus P, Zacharowski K. Linking inflammation and coagulation: novel drug targets to treat organ ischemia. Curr Opin Anaesthesiol 2011;24:375-380.
5. Damman J, Bloks VW, Daha MR et al. Hypoxia and complement-andcoagulation pathways in the deceased organ donor as the major target for intervention to improve renal allograft outcome. Transplantation 2015;99:1293-1300.
6. Buchmann K. Evolution of innate immunity: clues from invertebrates via fish to mammals. Front Immunol 2014;5:459.
7. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454:428-435.
8. Hickey MJ, Kubes P. Intravascular immunity: the host-pathogen encounter in blood vessels. Nat Rev Immunol 2009;9:364-375.
9. Anders HJ. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 2010;21:1270-1274.
10. Leventhal JS, Schröppel B. Toll-like receptors in transplantation: sensing and reacting to injury. Kidney Int 2012;81:826-832.
11. Chan JK, Roth J, Oppenheim JJ et al. Alarmins: awaiting a clinical response. J Clin Invest 2012;122:2711-2719.
12. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013;38:209-223.
13. McCarthy CG, Goulopoulou S, Wenceslau CF et al. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol 2014;306:H184-H196.
14. Niessen F, Schaffner F, Furlan-Freguia C et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 2008;452: 654-658.
15. Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately Blood 2009;114:2367-2374.
16. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13:34-45.
17. Wu Y. Contact pathway of coagulation and inflammation. Thromb J 2015;13:17.
18. Palabrica T, Lobb R, Furie BC et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848-851.
19. Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011;11:264-274.
20. Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood 2014;123:2768-2776.
21. Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol 2012;13:191-211.
22. Hotchkiss RS, Coopersmith CM, McDunn JE et al. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009;15:496-497.
23. Plikus MV, Gay DL, Treffeisen E et al. Epithelial stem cells and implications for wound repair. Semin Cell Dev Biol 2012;23: 946-953.
24. Sun BK, Siprashvili Z, Khavari PA. Advances in skin grafting and treatment of cutaneous wounds. Science 2014;346:941-945.
25. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemos 2011;105:S13-S33.
26. Braun RK, Ferrick C, Neubauer P et al. IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury. Inflammation 2008;31:167-179.
27. Ishida Y, Gao JL, Murphy PM. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 2008;180:569-579.
28. Pickert G, Neufert C, Leppkes M et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206:1465-1472.
29. Ebihara N, Matsuda A, Nakamura S et al. Role of the IL-6 classic-and trans-signaling pathways in corneal sterile inflammation and wound healing. Invest Ophthalmol Vis Sci 2011;52:8549-8557.
30. Kroeze KL, Boink MA, Sampat-Sardjoepersad SC et al. Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. J Invest Dermatol 2012;132:216-225.
31. Chen L, Guo S, Ranzer MJ et al. Toll-like receptor 4 has an essential role in early skin wound healing. J Invest Dermatol 2013;133: 258-267.
32. McGee HM, Schmidt BA, Booth CJ et al. IL-22 promotes fibroblastmediated wound repair in the skin. J Invest Dermatol 2013;133: 1321-1329.
33. Lai WF, Siu PM. MicroRNAs as regulators of cutaneous wound healing. J Biosci 2014;39:519-524.
34. Rosa A, Ballarino M, Sorrentino A et al. The interplay between the master transcription factor PU. 1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA 2007;104:19849-19854.
35. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P et al. miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ 2008;15:1187-1195.
36. Liu G, Friggeri A, Yang Y et al. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA 2009;106: 15819-15824.
37. Wang T, Feng Y, Sun H et al. miR-21 regulates skin wound healing by targeting multiple aspects of the healing process. Am J Pathol 2012;181:1911-1920.
38. Sallustio F, Costantino V, Cox SN et al. Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin. Kidney Int 2013;83:392-403.
39. Vaughan AE, Brumwell AN, Xi Y et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature 2015;517:621-625.
40. Ryu M, Migliorini A, Miosge N et al. Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in noninflammatory glomerular injury. J Pathol 2012;228:482-494.
41. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007;117:524-529.
42. Yang L, Besschetnova TY, Brooks CR et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010;16:535-543.
43. Niedermeier M, Reich B, Rodriguez Gomez M et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009;106:17892-17897.
44. Chen G, Lin SC, Chen J et al. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 2011;22: 1876-1886.
45. Xia Y, Yan J, Jin X et al. The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis. Kidney Int 2014;86:327-337.
46. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010;176:85-97.
47. LeBleu VS, Taduri G, O'Connell J et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013;19:1047-1053.
48. Falke LL, Gholizadeh S, Goldschmeding R et al. Diverse origins of the myofibroblast-implications for kidney fibrosis. Nat Rev Nephrol 2015;11:233-244.
49. Vielhauer V, Kulkarni O, Reichel CA et al. Targeting the recruitment of monocytes and macrophages in renal disease. Semin Nephrol 2010;30:318-333.
50. Martinez-Barricarte R, Pianetti G, Gautard R et al. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2008;19:639-646.
51. Hofer J, Janecke AR, Zimmerhackl LB et al. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2013;8:407-415.
52. Chapman K, Seldon M, Richards R. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13. Semin Thromb Hemost 2012;38:47-54.
53. Srivastava A, Rao GK, Segal PE et al. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody. Clin Rheumatol 2013;32:1317-1322.
54. Sorensen I, Susnik N, Inhester T et al. Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int 2011;80:1035-1044.
55. Loof TG, Morgelin M, Johansson L et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood 2011;118:2589-2598.
56. Vivante A, Calderon-Margalit R, Skorecki K. Hematuria and risk for end-stage kidney disease. Curr Opin Nephrol Hypertens 2013;22: 325-330.
57. Yuste C, Rubio-Navarro A, Barraca D et al. Haematuria increases progression of advanced proteinuric kidney disease. PLoS One 2015;10:e0128575.
58. Gutiérrez E, Egido J, Rubio-Navarro A et al. Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract 2012;121:c42-c53.
59. Degen JL, Bugge TH, Goguen JD. Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 2007;5:24-31.
60. Nelson PJ, Rees AJ, Griffin MD et al. The renal mononuclear phagocytic system. J Am Soc Nephrol 2012;23:194-203.
61. Anders HJ, Banas B, Schlondorff D. Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004;15:854-867.
62. Anders HJ, Schlondorff D. Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens 2007;16:177-183.
63. Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol 2011;22:1007-1018.
64. Lichtnekert J, Kulkarni OP, Mulay SR et al. Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1. PLoS One 2011;6: e26778.
65. Abais JM, Xia M, Li G et al. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxininteracting protein (TXNIP) during hyperhomocysteinemia. J Biol Chem 2014;289:27159-27168.
66. Shahzad K, Bock F, Dong W et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int 2015;87:74-84.
67. Wu H, Ma J, Wang P et al. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol. 2010;21:1878-1890.
68. Mudaliar H, Pollock C, Komala MG et al. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 2013;305:F143-F154.
69. R Nair A, Ebenezer PJ, Saini Y et al. Angiotensin II-induced hypertensive renal inflammation is mediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells. Exp Cell Res 2015;S0014-4827: 00191-00193.
70. Säemann MD, Weichhart T, Zeyda M et al. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 2005;115: 468-475.
71. Linkermann A, Green DR. Necroptosis. N Engl J Med 2014;370: 455-465.
72. Linkermann A, Stockwell BR, Krautwald S et al. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat Rev Immunol 2014;14:759-767.
73. Noris M, Cassis P, Azzollini N et al. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J Immunol 2009;183:4249-4260.
74. Lech M, Avila-Ferrufino A, Allam R et al. Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. J Immunol 2009;183:4109-4118.
75. Lassen S, Lech M, Rommele C et al. Ischemia reperfusion induces IFN regulatory factor 4 in renal dendritic cells, which suppresses postischemic inflammation and prevents acute renal failure. J Immunol 2010;185:1976-1983.
76. Allam R, Kumar SV, Darisipudi MN et al. Extracellular histones in tissue injury and inflammation. J Mol Med (Berl) 2014;92:465-472.
77. Xu J, Zhang X, Pelayo R et al. Extracellular histones are major mediators of death in sepsis. Nat Med 2009;15:1318-1321.
78. Allam R, Scherbaum CR, Darisipudi MN et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 2012;23:1375-1388.
79. Allam R, Darisipudi MN, Tschopp J et al. Histones trigger sterile inflammation by activating the NLRP3 inflammasome. Eur J Immunol 2013;43:3336-3342.
80. Kumar SV, Kulkarni OP, Mulay SR et al. Neutrophil extracellular traprelated extracellular histones cause vascular necrosis in severe GN. J Am Soc Nephrol 2015;26:2399-2413.
81. Ryu M, Kulkarni OP, Radomska E et al. Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-alpha-mediated podocyte loss. Kidney Int 2011;79:189-198.
82. Brahler S, Ising C, Hagmann H et al. Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria. Am J Physiol Renal Physiol 2012;303: F1473-F1485.
83. Leadbetter EA, Rifkin IR, Hohlbaum AM et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603-607.
84. Wen ZK, Xu W, Xu L et al. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 2007;46:1796-1803.
85. Villanueva E, Yalavarthi S, Berthier CC et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011;187:538-552.
86. Migliorini A, Anders HJ. A novel pathogenetic concept-antiviral immunity in lupus nephritis. Nat Rev Nephrol 2012;8:183-189.
87. Flur K, Allam R, Zecher D et al. Viral RNA induces type I interferondependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: implications for viral infection-associated glomerulonephritis. Am J Pathol 2009;175: 2014-2022.
88. Hagele H, Allam R, Pawar RD et al. Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a Toll-like receptor-independent cytosolic DNA recognition pathway. Am J Pathol 2009;175:1896-1904.
89. Migliorini A, Angelotti ML, Mulay SR et al. The antiviral cytokines IFN-and IFN-modulates parietal epithelial cells and promotes podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol 2013;183:431-440.
90. Anders HJ, Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 2011;80:915-925.
91. Lech M, Grobmayr R, Weidenbusch M et al. Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments. Mediators Inflamm 2012;2012:951390.
92. Brinkmann V, Reichard U, Goosmann C et al. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532-1535.
93. Anders HJ, Banas B, Linde Y et al. Bacterial CpG-DNA aggravates immune complex glomerulonephritis: Role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol 2003;14:317-326.
94. Sayyed SG, Ryu M, Kulkarni OP et al. An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int 2011;80:68-78.
95. Urushihara M, Ohashi N, Miyata K et al. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension 2011;57:586-593.
96. Seok SJ, Lee ES, Kim GT et al. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Nephrol Dial Transplant 2013;28:1700-1710.
97. Babel N, Volk HD, Reinke P. BK polyomavirus infection and nephropathy: the virus-immune system interplay. Nat Rev Nephrol 2011;7:399-406.
98. Ribeiro A, Wornle M, Motamedi N et al. Activation of innate immune defense mechanisms contributes to polyomavirus BK-associated nephropathy. Kidney Int 2012;81:100-111.
99. Anders HJ, Patole PS. Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract. Nephrol Dial Transplant 2005;20:1529-1532.
100. Patole PS, Schubert S, Hildinger K et al. Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int 2005;68:2582-2587.
101. Yang CW, Hung CC, Wu MS et al. Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int 2006;69:815-822.
102. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 2003;14: S55-S61.
103. Duffield JS, Park KM, Hsiao LL et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005;115:1743-1755.
104. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870.
105. Sugimoto H, Lebleu VS, Bosukonda D et al. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 2012;18:396-404.
106. Mulay SR, Thomasova D, Ryu M et al. MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice. Kidney Int 2012;81:1199-1211.
107. Weidenbusch M, Anders HJ. Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis. J Innate Immun 2012;4:463-477.
108. Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115:56-65.
109. Alikhan MA, Jones CV, Williams TM et al. Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am J Pathol 2011;179:1243-1256.
110. Iwata Y, Boström EA, Menke J et al. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupussusceptible mice. J Immunol. 2012;188:4568-4580.
111. Smeets B, Angelotti ML, Rizzo P et al. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 2009;20:2593-2603.
112. Bollee G, Flamant M, Schordan S et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat. Med 2011;17:1242-1250.
113. Hodgin JB, Bitzer M, Wickman L et al. Glomerular aging and focal global glomerulosclerosis: a podometric perspective. J Am Soc Nephrol 2015;26:3162-3178.
114. Lasagni L, Romagnani P. Basic research: podocyte progenitors and ectopic podocytes. Nat Rev Nephrol 2013;9:715-716.
115. Liapis H, Romagnani P, Anders HJ. New insights into the pathology of podocyte loss: mitotic catastrophe. Am J Pathol 2013;183:1364-1374.
116. Mulay SR, Thomasova D, Ryu M et al. Podocyte loss involves MDM2-driven mitotic catastrophe. J Pathol 2013;230:322-335.
117. Fukuda A, Chowdhury MA, Venkatareddy MP et al. Growthdependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol 2012;23:1351-1363.
118. Wanner N, Hartleben B, Herbach N et al. Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol 2014;25:707-716.
119. Sugimoto H, Mundel TM, Sund M et al. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci USA 2006;103:7321-7326.
120. Prodromidi EI, Poulsom R, Jeffery R et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 2006;24: 2448-2455.
121. Zoja C, Garcia PB, Rota C et al. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy. Am J Physiol Renal Physiol 2012;303:F1370-F1381.
122. Lasagni L, Romagnani P. Glomerular epithelial stem cells: the good, the bad, and the ugly. J Am Soc Nephrol 2010;21:1612-1619.
123. Shankland SJ, Pippin JW, Duffield JS. Progenitor cells and podocyte regeneration. Semin Nephrol 2014;34:418-428.
124. Lasagni L, Ballerini L, Angelotti ML et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 2010;28: 1674-1685.
125. Darisipudi MN, Kulkarni OP, Sayyed SG et al. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. Am J Pathol 2011;179:116-124.
126. Gaikwad AB, Sayyed SG, Lichtnekert J et al. Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes. Am J Pathol 2010;176:1079-1083.
127. Sayyed SG, Gaikwad AB, Lichtnekert J et al. Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol Dial Transplant 2010;25:1811-1817.
128. Menke J, Iwata Y, Rabacal WA et al. CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice. J Clin Invest 2009;119:2330-2342.
129. Angelotti ML, Ronconi E, Ballerini L et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012;30: 1714-1725.
130. Humphreys BD, Czerniak S, DiRocco DP et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci USA 2011;108:9226-9231.
131. Romagnani P. Family portrait: renal progenitor of Bowman's capsule and its tubular brothers. Am J Pathol 2011;178:490-493.
132. Schrimpf C, Xin C, Campanholle G et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 2012;23:868-883.
133. Campanholle G, Ligresti G, Gharib SA et al. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol 2013;304:C591-C603.
134. Grgic I, Campanholle G, Bijol V et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 2012;82: 172-183.
135. Zoja C, Abbate M, Remuzzi G. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration. Nephrol Dial Transplant 2015;30:706-712.
136. Imasawa T, Utsunomiya Y, Kawamura T et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 2001;12:1401-1409.
137. Ikarashi K, Li B, Suwa M et al. Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int 2005;67:1925-1933.
138. Daniel C, Albrecht H, Lüdke A et al. Nestin expression in repopulating mesangial cells promotes their proliferation. Lab Invest 2008;88: 387-397.
139. Pippin JW, Sparks MA, Glenn ST et al. Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease. Am J Pathol 2013;183:542-557.
140. Starke C, Betz H, Hickmann L et al. Renin lineage cells repopulate the glomerular mesangium after injury. J Am Soc Nephrol 2015;26:48-54.
141. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis - A new look at an old entity. N Engl J Med 2012;366:1119-1131.
142. Smeets B, Kuppe C, Sicking EM et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 2011;22:1262-1274.
143. Shankland SJ, Anders HJ, Romagnani P. Glomerular parietal epithelial cells in kidney physiology, pathology, and repair. Curr Opin Nephrol Hypertens 2013;22:302-309.
144. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2011;365:2398-2411.
145. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010;21:1819-1834.
146. Böger CA, Gorski M, Li M et al. Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet 2011;7: e1002292.
147. Anders HJ, Vielhauer V, Schlondorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 2003;63:401-415.
148. Vielhauer V, Berning E, Eis V et al. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 2004;66:2264-2278.
149. Anders HJ, Ninichuk V, Schlondorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 2006;69:29-32.
150. Furuichi K, Gao JL, Murphy PM. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am J Pathol 2006;169:372-387.
151. Clauss S, Gross O, Kulkarni O et al. Ccl2/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy. J Pathol 2009;218:40-47.
152. Liu L, Kou P, Zeng Q et al. CD4+ T Lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis. Am J Nephrol 2012;36: 386-396.
153. Lee S, Huen S, Nishio H et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011;22: 317-326.
154. Braga TT, Correa-Costa M, Guise YF et al. MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages. Mol Med 2012;18: 1231-1239.
155. Chen G, Chen H, Wang C et al. Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts. PLoS One 2012;7:e33626.
156. Cao Q, Harris DC, Wang Y. Macrophages in kidney injury, inflammation, and fibrosis. Physiology (Bethesda) 2015;30:183-194.
157. Sakai N, Wada T, Yokoyama H et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006;103:14098-14103.
158. Reich B, Schmidbauer K, Rodriguez Gomez M et al. Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model. Kidney Int 2013;84:78-89.
159. Kramann R, Humphreys BD. Kidney pericytes: roles in regeneration and fibrosis. Semin Nephrol 2014;34:374-383.
160. Migliorini A, Ebid R, Scherbaum CR et al. The danger control concept in kidney disease: mesangial cells. J Nephrol 2013;26:437-449.
161. Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol 2012;8:634-642.
162. Stout LC, Kumar S, Whorton EB. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson nodule. Hum Pathol 1993;24: 77-89.
163. Ninichuk V, Gross O, Segerer S et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006;70:121-129.
164. Kaissling B, Lehir M, Kriz W. Renal epithelial injury and fibrosis. Biochim Biophys Acta 2013;1832:931-939.
165. Venkatachalam MA, Weinberg JM, Kriz W et al. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol 2015;26:1765-1776.
166. Jia Z, Johnson AC, Wang X et al. Allelic variants in Arhgef11 via the Rho-Rock pathway are linked to epithelial-mesenchymal transition and contributes to kidney injury in the Dahl salt-sensitive rat. PLoS One 2015;10:e0132553.
167. Chen Y, Rao F, Wen G et al. Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease. Cell Mol Neurobiol 2010;30:1395-1400.